Jarl Jensen is the Founder and President of Inventagon, a company creating simpler research and development solutions for organizations across the globe.
Jarl holds patents for medical technologies that have enjoyed sales over one-billion dollars. His success led him to chair several organizations including New Jersey’s YPO chapter, and found EuroMed, Inc., a company he sold in 2016. But this success is just a part of Jarl’s story.
Jarl sees the broken systems around us—the inequality and the propping up of a failed status quo—and seeks solutions. Since 2017, Jarl has been writing books that have topped best-seller lists and changed the discourse surrounding the economy, society, and our shared future.
His vision, direction, and purpose bleed onto every page he writes. Jarl’s philosophy is rooted in the cold, hard facts that led us here yet he proposes a path forward that is supremely optimistic.
Having received his B.S. in Mechanical Engineering from Boston University, Jarl’s strategies are not simply pie-in-the-sky ideas, they are analytical, detailed, and aimed boldly at creating solutions in our lifetime.
Jarl Jensen served as President and Chief Executive Officer of EuroMed, Inc. from 2004 to 2009. He has more than 10 years of experience in the hydrocolloid health technology business. During this time, he has been issued eight patents with many more pending.
Jarl served as Research and Development Manager, where he was involved with the machine design, product design and formulation of the products sold by EuroMed today. He has developed a unique market and industry expertise for hydrocolloid technologies, manufacturing processes and the commercialization of advanced wound care products.
Jarl leads a team of experienced professionals whom have helped to create this wound care category and perpetuate its clinical efficacy in treating hard to heal wounds and improve quality of life. He serves as a Director of Euromed Inc.